Ricovr Healthcare is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry, NAICS Code 54171.
Investor Activity
Ricovr Healthcare has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
December 13, 2023
1
50%
$4 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Ricovr Healthcare is developing and marketing.
Ricovr Healthcare doesn't have any recent trademark applications, indicating Ricovr Healthcare is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
XALIVA Medical diagnostic apparatus for testing of saliva to detect drugs and diagnose disease; Medical imaging apparatus for saliva testing to detect presence of drugs and diseases
06/18/2020
See all trademarks and details in the Full Report.
Market Share of Ricovr Healthcare's Largest Competitors
A competitive analysis shows these companies are in the same general field as Ricovr Healthcare, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Ricovr Healthcare.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Ricovr Healthcare and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.